All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Hepatitis B, Chronic-28303969
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 28303969 H124N
RT
P
Hepatitis B, Chronic
D
G
R
L
View
2 28303969 A181T
RT
P
Hepatitis B, Chronic
G
R
L
View
3 28303969 M204V
RT
P
Hepatitis B, Chronic
G
R
L
View
4 28303969 F122L
RT
P
Hepatitis B, Chronic
G
R
L
View
5 28303969 H122L
RT
P
Hepatitis B, Chronic
G
R
L
View
6 28303969 Q130P
RT
P
Hepatitis B, Chronic
G
R
L
View
7 28303969 N131D
RT
P
Hepatitis B, Chronic
G
R
L
View
8 28303969 A219S
RT
P
Hepatitis B, Chronic
G
R
L
View
9 28303969 H248N
RT
P
Hepatitis B, Chronic
G
R
L
View
10 28303969 S256C
RT
P
Hepatitis B, Chronic
G
R
L
View
11 28303969 R266I
RT
P
Hepatitis B, Chronic
G
R
L
View
12 28303969 H267Q
RT
P
Hepatitis B, Chronic
G
R
L
View
13 28303969 L267Q
RT
P
Hepatitis B, Chronic
G
R
L
View
14 28303969 A113T
S
S
Hepatitis B, Chronic
G
R
I
L
View
15 28303969 A128V
S
S
Hepatitis B, Chronic
G
R
I
L
View
16 28303969 A194V
S
S
Hepatitis B, Chronic
G
R
I
L
View
17 28303969 I195M
S
S
Hepatitis B, Chronic
G
R
I
L
View
18 28303969 I4T
S
S
Hepatitis B, Chronic
G
R
I
L
View
19 28303969 K160R
S
S
Hepatitis B, Chronic
G
R
I
L
View
20 28303969 L49P
S
S
Hepatitis B, Chronic
G
R
I
L
View
21 28303969 M204I
RT
P
Hepatitis B, Chronic
G
R
L
View
22 28303969 N131T
S
S
Hepatitis B, Chronic
G
R
I
L
View
23 28303969 N143S
S
S
Hepatitis B, Chronic
G
R
I
L
View
24 28303969 N3S
S
S
Hepatitis B, Chronic
G
R
I
L
View
25 28303969 P127T
S
S
Hepatitis B, Chronic
G
R
I
L
View
26 28303969 R210N
S
S
Hepatitis B, Chronic
G
R
I
L
View
27 28303969 S113T
S
S
Hepatitis B, Chronic
G
R
I
L
View
28 28303969 S161F
S
S
Hepatitis B, Chronic
G
R
I
L
View
29 28303969 S45A
S
S
Hepatitis B, Chronic
G
R
I
L
View
30 28303969 S53L
S
S
Hepatitis B, Chronic
G
R
I
L
View
31 28303969 T114S
S
S
Hepatitis B, Chronic
G
R
I
L
View
32 28303969 T118V
S
S
Hepatitis B, Chronic
G
R
I
L
View
33 28303969 T126I
S
S
Hepatitis B, Chronic
G
R
I
L
View
34 28303969 V47T
S
S
Hepatitis B, Chronic
G
R
I
L
View
35 28303969 W196L
S
S
Hepatitis B, Chronic
G
R
I
L
View
36 28303969 Y161F
S
S
Hepatitis B, Chronic
G
R
I
L
View
37 28303969 V278I
RT
P
Hepatitis B, Chronic
G
R
L
View
38 28303969 I68A
S
S
Hepatitis B, Chronic
G
R
I
L
View
39 28303969 I68T
S
S
Hepatitis B, Chronic
G
R
I
L
View
40 28303969 P46T
S
S
Hepatitis B, Chronic
G
R
I
L
View
41 28303969 S202G
RT
P
Hepatitis B, Chronic
G
R
L
View
42 28303969 T118N
RT
P
Hepatitis B, Chronic
G
R
L
View
43 28303969 T125M
S
S
Hepatitis B, Chronic
G
R
I
L
View
44 28303969 L80I
RT
P
Hepatitis B, Chronic
G
R
L
View
45 28303969 L180M
RT
P
Hepatitis B, Chronic
G
R
L
View
46 28303969 N53D
RT
P
Hepatitis B, Chronic
G
R
L
View
47 28303969 Y54H
RT
P
Hepatitis B, Chronic
G
R
L
View
48 28303969 L91I
RT
P
Hepatitis B, Chronic
G
R
L
View
49 28303969 I121L
RT
P
Hepatitis B, Chronic
G
R
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.